TLDR Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.
The study focused on Frontal Fibrosing Alopecia (FFA), a type of primary lymphocytic scarring alopecia, and analyzed epidemiological data from 300 patients at the "A. Syggros" hospital over 10 years. The majority of patients were women (94.7%), with ages ranging from 26 to 92 years and an average age of 61.7. A significant portion of the women (82.7%) were postmenopausal. The study found that 56.3% of participants had thyroid disease, 34% had hyperlipidemia, and 22.7% had anemia, among other conditions. Additionally, 40.3% had a family history of androgenetic alopecia, and 13.3% had a family history of FFA. The findings aligned with international studies on FFA.
8 citations
,
October 2016 in “Actas Dermo-Sifiliográficas” FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.
April 2025 in “Diagnostics” Managing inflammation and using vitamins can improve PRP therapy for better hair growth.
76 citations
,
July 2011 in “Clinical, Cosmetic and Investigational Dermatology” The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.
Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.
1 citations
,
October 2013 in “Expert Review of Dermatology” Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.
